USA – The FDA vaccine advisory board recommends booster shots of both the J&J and Moderna vaccines

The Food and Drug Administration (FDA)’s Vaccines and Related Biological Products Advisory Committee has voted unanimously to recommend a second shot of Johnson & Johnson (J&J)’s COVID vaccine for the more than 15 million adults who have already received a dose.

While the FDA usually follows the advice of its advisory committee, a final decision cannot be made until the vaccine advisory group of the Centers for Disease Control and Prevention (CDC) has recommended the second jab, although this is expected within days.

“Today’s recommendation is based on the totality of evidence, with clinical and real-world data showing that while a single shot offers strong and long-lasting protection against COVID-19, a booster given after the single-dose primary vaccination increases protection, in particular against symptomatic COVID-19,” said Paul Stoffels, chief scientific officer at J&J…